Predictive Oncology INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Predictive Oncology Inc. faces a "going concern" warning and seeks shareholder approval for significant equity issuance and an expanded incentive plan amidst substantial net losses and declining shareholder returns.
Predictive Oncology Inc. calls a Special Meeting to approve a 1:15 reverse stock split and a $10 million equity raise to maintain Nasdaq listing compliance.
Predictive Oncology Inc. has scheduled its annual stockholder meeting for December 30, 2024, to vote on the election of directors, ratification of auditors, approval of an equity incentive plan, and executive compensation.